NewAmsterdam (NAMS) via Frazier Lifesciences (FLAC) deck

NewAmsterdam Pharma is a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases.

Debarshi Ghosh

This post is for subscribers only

Subscribe

Already have an account? Log in

You might also like

Sakuu (SAKU) via Plum Acq Corp. I (PLMI) deck Members Public

Sakuu is the inventor of high-volume multi-material, multi-process Kavian™ additive manufacturing platforms to produce SwiftPrint™ batteries and other complex active devices.

Debarshi Ghosh
Technology

D-Wave (QBTS) via DPCM Capital (XPOA) deck Members Public

D-Wave is a leader in the development and delivery of quantum computing systems, software and services, and is the world’s first commercial supplier of quantum computers.

Debarshi Ghosh
SPAC IPO Slides

Featured Posts

Heidmar looks good for a company in shipping.

MoneyLion Mirage

Striking Warrant Gold

Authors →

Debarshi Ghosh

Kris Tuttle

Developed AI (OPS) applications at CMU and then IBM in the 80's and 90's. Went to Wall Street with an MBA in Finance. Retired in 2004 to focus on independent investment research and active investing.